Home › Transthyretin-Related Hereditary Amyloidosis › Florida › Jacksonville
Transthyretin-Related Hereditary Amyloidosis clinical trials in Jacksonville, FL
3 studies for Transthyretin-Related Hereditary Amyloidosis are looking for participants at sites in and around Jacksonville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
RecruitingObservational study
- Clinical Trial Site, Jacksonville
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- Mayo Clinic - Jacksonville, Jacksonville
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
RecruitingPhase 3
- Mayo Clinic - Jacksonville, Jacksonville
Transthyretin-Related Hereditary Amyloidosis trials in other cities
- Los Angeles, CA5 studies
- New York City, NY5 studies
- Durham, NC4 studies
- Philadelphia, PA4 studies
- Dallas, TX4 studies
- Boston, MA4 studies
- Portland, OR4 studies
- San Diego, CA4 studies
- Baltimore, MD4 studies
- Chicago, IL3 studies
- Washington, DC3 studies
- Rochester, MN3 studies
Other studies in Jacksonville
- Breast Cancer40 studies
- Non-Small Cell Lung Cancer39 studies
- Cancer (all types)29 studies
- Metastatic Cancer28 studies
- Colorectal Cancer27 studies
- Prostate Cancer26 studies
- Obesity25 studies
- Heart Failure21 studies
- Pancreatic Cancer20 studies
- Overweight19 studies
- Multiple Myeloma18 studies
- Lung Cancer17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.